Cargando…

Risk factors for peripartum hysterectomy among women with postpartum haemorrhage: analysis of data from the WOMAN trial

BACKGROUND: Peripartum hysterectomy can cause significant morbidity and mortality. Most studies of peripartum hysterectomy are from high income countries. This cohort study examined risk factors for peripartum hysterectomy using data from Africa, Asia, Europe and the Americas. METHODS: We used data...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huque, Sumaya, Roberts, Ian, Fawole, Bukola, Chaudhri, Rizwana, Arulkumaran, Sabaratnam, Shakur-Still, Haleema
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975404/ https://www.ncbi.nlm.nih.gov/pubmed/29843627 http://dx.doi.org/10.1186/s12884-018-1829-7

Ejemplares similares

The impact of early outcome events on the effect of tranexamic acid in post-partum haemorrhage: an exploratory subgroup analysis of the WOMAN trial
por: Brenner, Amy, et al.
Publicado: (2018)

Tranexamic acid for the prevention of postpartum bleeding in women with anaemia: study protocol for an international, randomised, double-blind, placebo-controlled trial
por: Ker, Katharine, et al.
Publicado: (2018)

Secondary analysis of the WOMAN trial to explore the risk of sepsis after invasive treatments for postpartum hemorrhage
por: Cornelissen, Laura, et al.
Publicado: (2019)

The WOMAN trial: clinical and contextual factors surrounding the deaths of 483 women following post-partum haemorrhage in developing countries
por: Picetti, Roberto, et al.
Publicado: (2020)

Effect of tranexamic acid on coagulation and fibrinolysis in women with postpartum haemorrhage (WOMAN-ETAC): protocol and statistical analysis plan for a randomized controlled trial
por: Shakur, Haleema, et al.
Publicado: (2016)

Tranexamic acid by the intramuscular or intravenous route for the prevention of postpartum haemorrhage in women at increased risk: a randomised placebo-controlled trial (I’M WOMAN)
por: Brenner, Amy, et al.
Publicado: (2023)

Effect of tranexamic acid on coagulation and fibrinolysis in women with postpartum haemorrhage (WOMAN-ETAC): a single-centre, randomised, double-blind, placebo-controlled trial
por: Shakur-Still, Haleema, et al.
Publicado: (2018)

Risk factors for blood transfusion in traumatic and postpartum hemorrhage patients: Analysis of the CRASH-2 and WOMAN trials
por: Kolin, David A., et al.
Publicado: (2020)

Tranexamic acid for the prevention of postpartum bleeding in women with anaemia: Statistical analysis plan for the WOMAN-2 trial: an international, randomised, placebo-controlled trial
por: Collier, Tim, et al.
Publicado: (2023)

Haematological and fibrinolytic status of Nigerian women with post-partum haemorrhage
por: Roberts, Ian, et al.
Publicado: (2018)

No effect of tranexamic acid on platelet function and thrombin generation (ETAPlaT) in postpartum haemorrhage: a randomised placebo-controlled trial
por: Dallaku, Kastriot, et al.
Publicado: (2019)

Postpartum haemorrhage in anaemic women: assessing outcome measures for clinical trials
por: Brenner, Amy, et al.
Publicado: (2022)

The effect of tranexamic acid on the risk of death and hysterectomy in women with post-partum haemorrhage: statistical analysis plan for the WOMAN trial
por: Shakur, Haleema, et al.
Publicado: (2016)

Tranexamic acid for significant traumatic brain injury (The CRASH-3 trial): Statistical analysis plan for an international, randomised, double-blind, placebo-controlled trial
por: Roberts, Ian, et al.
Publicado: (2018)

Tranexamic acid for post-partum haemorrhage: What, who and when
por: Brenner, Amy, et al.
Publicado: (2019)

WOMAN-PharmacoTXA trial: Study protocol for a randomised controlled trial to assess the pharmacokinetics and pharmacodynamics of intramuscular, intravenous and oral administration of tranexamic acid in women giving birth by caesarean section
por: Arribas, Monica, et al.
Publicado: (2021)

Cost-effectiveness analysis of tranexamic acid for the treatment of traumatic brain injury, based on the results of the CRASH-3 randomised trial: a decision modelling approach
por: Williams, Jack, et al.
Publicado: (2020)

Tranexamic acid for treatment of women with post-partum haemorrhage in Nigeria and Pakistan: a cost-effectiveness analysis of data from the WOMAN trial
por: Li, Bernadette, et al.
Publicado: (2018)

Statistical analysis plan for the WOMAN-ETAPlaT study: Effect of tranexamic acid on platelet function and thrombin generation
por: Dallaku, Kastriot, et al.
Publicado: (2017)

The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial
por: Shakur, Haleema, et al.
Publicado: (2010)

A nested randomised trial of the effect of tranexamic acid on intracranial haemorrhage and infarction in traumatic brain injury (CRASH-3 trial intracranial bleeding mechanistic study): Statistical analysis plan
por: Mahmood, Abda, et al.
Publicado: (2019)

Antifibrinolytic Agents in Traumatic Haemorrhage
por: Coats, Tim, et al.
Publicado: (2005)

Tranexamic acid for the prevention of postpartum bleeding: Protocol for a systematic review and individual patient data meta-analysis
por: Ker, Katharine, et al.
Publicado: (2023)

Outcome measures in clinical trials of treatments for acute severe haemorrhage
por: Brenner, Amy, et al.
Publicado: (2018)

Emergency peripartum hysterectomy in Isfahan; maternal mortality and morbidity rates among the women who underwent peripartum hysterectomy
por: Gurtani, Fatemeh Mostajeran, et al.
Publicado: (2013)

Anti-fibrinolytic agents in post partum haemorrhage: a systematic review
por: Ferrer, Pili, et al.
Publicado: (2009)

Alternative routes to intravenous tranexamic acid for postpartum hemorrhage: A systematic search and narrative review
por: Shakur‐Still, Haleema, et al.
Publicado: (2022)

Peripartum hysterectomy due to severe postpartum hemorrhage: A hospital‐based study
por: Pettersen, Silje, et al.
Publicado: (2022)

Effects of tranexamic acid treatment in severely and non‐severely injured trauma patients
por: Ageron, Francois‐Xavier, et al.
Publicado: (2022)

Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial
por: Brenner, Amy, et al.
Publicado: (2020)

Plasma Concentrations of Tranexamic Acid in Postpartum Women After Oral Administration
por: Muhunthan, Kopalasuntharam, et al.
Publicado: (2020)

Maternal outcome after abdominal packing for uncontrolled postpartum hemorrhage despite peripartum hysterectomy
por: Deffieux, Xavier, et al.
Publicado: (2017)

A nested mechanistic sub-study into the effect of tranexamic acid versus placebo on intracranial haemorrhage and cerebral ischaemia in isolated traumatic brain injury: study protocol for a randomised controlled trial (CRASH-3 Trial Intracranial Bleeding Mechanistic Sub-Study [CRASH-3 IBMS])
por: Mahmood, Abda, et al.
Publicado: (2017)

Postpartum haemorrhage: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data()
por: Kerr, Robbie, et al.
Publicado: (2016)

Accuracy of time to treatment estimates in the CRASH-3 clinical trial: impact on the trial results
por: Mansukhani, Raoul, et al.
Publicado: (2020)

A cost-effectiveness and value of information analysis to inform future research of tranexamic acid for older adults experiencing mild traumatic brain injury
por: Williams, Jack, et al.
Publicado: (2022)

What concentration of tranexamic acid is needed to inhibit fibrinolysis? A systematic review of pharmacodynamics studies
por: Picetti, Roberto, et al.
Publicado: (2019)

Trial management: we need a cadre of high-class triallists to deliver the answers that patients need
por: Beaumont, Danielle, et al.
Publicado: (2019)

Economic evaluation of tranexamic acid for the treatment of acute gastrointestinal bleeding: a cost-effectiveness analysis using data from the HALT-IT randomised controlled trial
por: Bazeer, Nuha, et al.
Publicado: (2022)

Tranexamic acid for gastrointestinal bleeding: can a reduction in the risk of death be discounted? A systematic review and meta-analysis of individual patient data from 64 724 bleeding patients
por: Ker, Katharine, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5io9d9vpda7naer8hmcmuh748v